Tolerability of statin-based management of patients with a history of statin-associated muscle symptoms: protocol for a systematic review
Introduction Statin-associated muscle symptoms (SAMSs) are a major clinical issue in the primary and secondary prevention of cardiovascular events. Current guidelines advise various approaches mainly based on expert opinion. We will lead a systematic review and meta-analysis to explore the tolerabil...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2021-08-01
|
Series: | BMJ Open |
Online Access: | https://bmjopen.bmj.com/content/11/8/e052341.full |
_version_ | 1819150756866949120 |
---|---|
author | Manuel R Blum Nicolas Rodondi Cinzia Del Giovane Fanny Villoz Christina Lyko |
author_facet | Manuel R Blum Nicolas Rodondi Cinzia Del Giovane Fanny Villoz Christina Lyko |
author_sort | Manuel R Blum |
collection | DOAJ |
description | Introduction Statin-associated muscle symptoms (SAMSs) are a major clinical issue in the primary and secondary prevention of cardiovascular events. Current guidelines advise various approaches mainly based on expert opinion. We will lead a systematic review and meta-analysis to explore the tolerability and acceptability and effectiveness of statin-based therapy management of patients with a history of SAMS. We aim to provide evidence on the tolerability and different strategies of statin-based management of patients with a history of SAMS.Methods and analysis We will conduct a systematic review of randomised controlled trials (RCTs) and non-randomised studies with a control group. We will search in Data sources MEDLINE, EMBASE, Cochrane Central Register of Controlled Clinical Trials, Scopus, Clinicaltrials.gov and Proquest from inception until April 2021. Two independent reviewers will carry out the study selection based on eligibility criteria. We will extract data following a standard data collection form. The reviewers will use the Cochrane Collaboration’s tools and Newcastle-Ottawa Scale to appraise the study risk of bias. Our primary outcome will be tolerability and our secondary outcomes will be acceptability and effectiveness. We will conduct a qualitative analysis of all included studies. In addition, if sufficient and homogeneous data are available, we will conduct quantitative analysis. We will synthesise dichotomous data using OR with 95% CI and continuous outcomes by using mean difference or standardised mean difference (with 95% CI). We will determine heterogeneity visually with forest plots and quantitatively with I2 and Q-test. We will summarise the confidence in the quantitative estimate by using Grading of Recommendations Assessment, Development and Evaluation approach.Ethics and dissemination As a systematic review of literature without collection of new clinical data, there will be no requirement for ethical approval. We will disseminate findings through peer-reviewed publications.PROSPERO registration number CRD42020202619. |
first_indexed | 2024-12-22T14:22:34Z |
format | Article |
id | doaj.art-7a1543b3ddb1451c8306db1e5c618b27 |
institution | Directory Open Access Journal |
issn | 2044-6055 |
language | English |
last_indexed | 2024-12-22T14:22:34Z |
publishDate | 2021-08-01 |
publisher | BMJ Publishing Group |
record_format | Article |
series | BMJ Open |
spelling | doaj.art-7a1543b3ddb1451c8306db1e5c618b272022-12-21T18:22:57ZengBMJ Publishing GroupBMJ Open2044-60552021-08-0111810.1136/bmjopen-2021-052341Tolerability of statin-based management of patients with a history of statin-associated muscle symptoms: protocol for a systematic reviewManuel R Blum0Nicolas Rodondi1Cinzia Del Giovane2Fanny Villoz3Christina Lyko4Institute of Primary Health Care (BIHAM), University of Bern, Bern, SwitzerlandInstitute of Primary Health Care (BIHAM), University of Bern, Bern, SwitzerlandInstitute of Primary Health Care (BIHAM), University of Bern, Bern, SwitzerlandInstitute of Primary Health Care (BIHAM), University of Bern, Bern, SwitzerlandInstitute of Primary Health Care (BIHAM), University of Bern, Bern, SwitzerlandIntroduction Statin-associated muscle symptoms (SAMSs) are a major clinical issue in the primary and secondary prevention of cardiovascular events. Current guidelines advise various approaches mainly based on expert opinion. We will lead a systematic review and meta-analysis to explore the tolerability and acceptability and effectiveness of statin-based therapy management of patients with a history of SAMS. We aim to provide evidence on the tolerability and different strategies of statin-based management of patients with a history of SAMS.Methods and analysis We will conduct a systematic review of randomised controlled trials (RCTs) and non-randomised studies with a control group. We will search in Data sources MEDLINE, EMBASE, Cochrane Central Register of Controlled Clinical Trials, Scopus, Clinicaltrials.gov and Proquest from inception until April 2021. Two independent reviewers will carry out the study selection based on eligibility criteria. We will extract data following a standard data collection form. The reviewers will use the Cochrane Collaboration’s tools and Newcastle-Ottawa Scale to appraise the study risk of bias. Our primary outcome will be tolerability and our secondary outcomes will be acceptability and effectiveness. We will conduct a qualitative analysis of all included studies. In addition, if sufficient and homogeneous data are available, we will conduct quantitative analysis. We will synthesise dichotomous data using OR with 95% CI and continuous outcomes by using mean difference or standardised mean difference (with 95% CI). We will determine heterogeneity visually with forest plots and quantitatively with I2 and Q-test. We will summarise the confidence in the quantitative estimate by using Grading of Recommendations Assessment, Development and Evaluation approach.Ethics and dissemination As a systematic review of literature without collection of new clinical data, there will be no requirement for ethical approval. We will disseminate findings through peer-reviewed publications.PROSPERO registration number CRD42020202619.https://bmjopen.bmj.com/content/11/8/e052341.full |
spellingShingle | Manuel R Blum Nicolas Rodondi Cinzia Del Giovane Fanny Villoz Christina Lyko Tolerability of statin-based management of patients with a history of statin-associated muscle symptoms: protocol for a systematic review BMJ Open |
title | Tolerability of statin-based management of patients with a history of statin-associated muscle symptoms: protocol for a systematic review |
title_full | Tolerability of statin-based management of patients with a history of statin-associated muscle symptoms: protocol for a systematic review |
title_fullStr | Tolerability of statin-based management of patients with a history of statin-associated muscle symptoms: protocol for a systematic review |
title_full_unstemmed | Tolerability of statin-based management of patients with a history of statin-associated muscle symptoms: protocol for a systematic review |
title_short | Tolerability of statin-based management of patients with a history of statin-associated muscle symptoms: protocol for a systematic review |
title_sort | tolerability of statin based management of patients with a history of statin associated muscle symptoms protocol for a systematic review |
url | https://bmjopen.bmj.com/content/11/8/e052341.full |
work_keys_str_mv | AT manuelrblum tolerabilityofstatinbasedmanagementofpatientswithahistoryofstatinassociatedmusclesymptomsprotocolforasystematicreview AT nicolasrodondi tolerabilityofstatinbasedmanagementofpatientswithahistoryofstatinassociatedmusclesymptomsprotocolforasystematicreview AT cinziadelgiovane tolerabilityofstatinbasedmanagementofpatientswithahistoryofstatinassociatedmusclesymptomsprotocolforasystematicreview AT fannyvilloz tolerabilityofstatinbasedmanagementofpatientswithahistoryofstatinassociatedmusclesymptomsprotocolforasystematicreview AT christinalyko tolerabilityofstatinbasedmanagementofpatientswithahistoryofstatinassociatedmusclesymptomsprotocolforasystematicreview |